P19-57 LB. Gene-based vaccination protects against mucosal infection by a heterologous highly pathogenic SIV isolate in rhesus monkeys

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1742-4690
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
P19-57 LB. Gene-based vaccination protects against mucosal infection by a heterologous highly pathogenic SIV isolate in rhesus monkeys ; volume:6 ; number:3 ; day:22 ; month:10 ; year:2009 ; pages:1 ; date:10.2009
Retrovirology ; 6, Heft 3 (22.10.2009), 1, 10.2009

Urheber
Letvin, N.
Beteiligte Personen und Organisationen
Mascola, J.
Rao, S.
Buzby, A.
Roederer, M.
Hudgens, M.
Gilbert, P.
Seder, R.
Douek, D.
Koup, R.
Graham, B.
Nabel, G.
SpringerLink (Online service)

DOI
10.1186/1742-4690-6-S3-P421
URN
urn:nbn:de:1111-2016080711087
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:48 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Letvin, N.
  • Mascola, J.
  • Rao, S.
  • Buzby, A.
  • Roederer, M.
  • Hudgens, M.
  • Gilbert, P.
  • Seder, R.
  • Douek, D.
  • Koup, R.
  • Graham, B.
  • Nabel, G.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

P19-38. Safety and protective immunity in Rhesus monkeys immunized with replication-defective HIV/SIV vaccine

P19-38. Safety and protective immunity in Rhesus monkeys immunized with replication-defective HIV/SIV vaccine

Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys

Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys

Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys

Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys

Origin of rebound virus in chronically SIV-infected Rhesus monkeys following treatment discontinuation

Origin of rebound virus in chronically SIV-infected Rhesus monkeys following treatment discontinuation

Immune control of an SIV challenge by a heterolgous and direct mucosal vaccination regimen in rhesus monkeys

Immune control of an SIV challenge by a heterolgous and direct mucosal vaccination regimen in rhesus monkeys

P04-41. Kinetics of antibody neutralization and viral evolution following envelope vaccination in SIV-infected rhesus monkeys

P04-41. Kinetics of antibody neutralization and viral evolution following envelope vaccination in SIV-infected rhesus monkeys

P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques

P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques

Turnover of Plasma Kininogens in Rhesus Monkeys

Turnover of Plasma Kininogens in Rhesus Monkeys

P03-07. Autologous neutralizing antibodies that select viral escape variants emerge late after SIV infection of rhesus monkeys

P03-07. Autologous neutralizing antibodies that select viral escape variants emerge late after SIV infection of rhesus monkeys

Plasma lipidomic signatures of spontaneous obese rhesus monkeys

Plasma lipidomic signatures of spontaneous obese rhesus monkeys

IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques

IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques

Evidence for Env-V2 sieve effect in breakthrough SIV MAC251 infections in rhesus monkeys vaccinated with Ad26/MVA and MVA/Ad26 constructs

Evidence for Env-V2 sieve effect in breakthrough SIV MAC251 infections in rhesus monkeys vaccinated with Ad26/MVA and MVA/Ad26 constructs

Verbundene Objekte